Zegruvirimat is an investigational antiretroviral agent classified as a non-nucleoside reverse transcriptase inhibitor (NNRTI) designed to treat HIV-1 infection by suppressing viral replication. This category… Read more
Zegruvirimat is an investigational antiretroviral agent classified as a non-nucleoside reverse transcriptase inhibitor (NNRTI) designed to treat HIV-1 infection by suppressing viral replication. This category offers high-quality reference standards for Zegruvirimat, including pharmacopeial and non-pharmacopeial impurities, potential metabolites, and stable isotope labelled compounds essential for rigorous analytical testing. Pharmaceutical laboratories utilize these materials to support precise impurity profiling, allowing for the accurate identification and quantification of degradation products or synthetic byproducts during stability studies. These standards are critical for method validation and routine quality control, ensuring that analytical assays remain reliable and compliant with regulatory expectations. By providing a comprehensive suite of well-characterized reference materials, this collection supports the development and manufacture of consistent antiviral therapies throughout the research and product lifecycle.